A couple of the ARK Invest exchange-traded funds run by ETF star Cathie Wood made huge sales on Thursday. These funds parted with over 280,000 shares of Square Inc. (NASDAQ: SQ), as their share prices gained less than 1% in Thursday’s session. Note that these funds just turned negative in terms of their year-over-year performance.
[in-text-ad]
ARK Innovation ETF (NYSEARCA: ARKK) sold 224,999 shares of Square and ARK Next Generation Internet ETF (NYSEARCA: ARKW) parted with 56,407 shares. At Thursday’s closing prices, this would have valued these sales at roughly $54.1 million. Even though this is a small fraction of the total holdings, every little bit counts. The innovation fund is down 10% in the past year, and the other is down closer to 2%.
Check out all of ARK Invest’s sales for Thursday as well:
| Fund | Ticker | Name | Shares |
|---|---|---|---|
| ARKF | SE | SEA | 25,293 |
| ARKF | TOST | TOAST | 189,033 |
| ARKG | DNA | GINKGO BIOWORKS | 782,292 |
| ARKG | SLGC | SOMALOGIC | 52,635 |
| ARKG | MASS | 908 DEVICES | 107,633 |
| ARKK | SQ | SQUARE | 224,999 |
| ARKK | TRMB | TRIMBLE | 11,942 |
| ARKK | TWLO | TWILIO | 106,322 |
| ARKK | VCYT | VERACYTE | 39,607 |
| ARKK | ZM | ZOOM VIDEO COMMUNICATIONS | 130,972 |
| ARKK | SGFY | SIGNIFY HEALTH | 9,550 |
| ARKK | RBLX | ROBLOX | 370,428 |
| ARKK | NTLA | INTELLIA THERAPEUTICS | 79,336 |
| ARKK | MTLS | MATERIALISE | 100,035 |
| ARKK | DNA | GINKGO BIOWORKS | 1,274,116 |
| ARKQ | ACHR | ARCHER AVIATION | 9,715 |
| ARKQ | BLDE | BLADE AIR MOBILITY | 44,343 |
| ARKQ | XPEV | XPENG | 277,263 |
| ARKQ | ISRG | INTUITIVE SURGICAL | 10,738 |
| ARKQ | VUZI | VUZIX | 189,161 |
| ARKQ | MKFG | MARKFORGED | 60,205 |
| ARKW | ZM | ZOOM VIDEO COMMUNICATIONS | 33,081 |
| ARKW | TWLO | TWILIO | 41,775 |
| ARKW | SQ | SQUARE | 56,407 |
| ARKW | SPLK | SPLUNK | 30,300 |
| ARKX | VLD | VELO3D | 92,524 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
